Nanostent announces the publication of the Quebec Terry 2 ™ Registry in  Catheterization & Cardiovascular Interventions Journal. https://doi.org/10.1002/ccd.70511 In this prospective registry of  578 patients , led by Dr. T. Cieza at Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ), Dr. F. Bonnenfant at Hôpital Chicoutimi, and Dr. J. MacHaalany at Hôtel Dieu de Québec, the  Terry 2 ™ radial hemostasis device  demonstrated: 100% patent hemostasis 0.2%

Nanostent is pleased to announce that the team of nurses and interventional cardiologists at IUCPQ have started the EASY-RAO study.

With current recommendations aiming to reduce the radial artery occlusion (RAO) incidence < 5% after transradial approach, Nanostent has...

Polymeric BVS Absorb technically more difficult to insert and deploy in coronary arteries compared to standard metallic drug eluting...